Navigation Links
International AIDS Society urges world leaders at UN General Assembly High-Level Meeting on HIV/AIDS to integrate a fourth pillar -- HIV cure research -- into the global response to the epidemic
Date:6/7/2011

07 June 2011. Geneva, Switzerland. As world leaders meet this week to review progress and chart the future course of the global AIDS response at the 2011 UN General Assembly High-Level Meeting on AIDS (UNGASS 2011) in New York, the International AIDS Society (IAS) calls on leaders to ensure the inclusion of HIV cure research and its global strategy into the international HIV agenda and in all discussions, political decisions and funding strategies.

In this historic month which marks both 30 years since the first reported AIDS cases and 10 years since the UNGASS Declaration of Commitment on HIV/AIDS was adopted the International AIDS Society is calling on all stakeholders in the global response to AIDS to adopt a new four pillar approach to combating the epidemic, by adding the fourth pillar, "cure", to the current three pillar approach of "prevention, treatment and care."

Globally, there are currently 33.3 million people living with HIV and, while much scientific progress has been made over the past three decades -- the greatest being the antiretroviral treatment (ART) which has ensured that millions of people living with HIV/AIDS can lead healthy lives-- there is still no cure for HIV.

Although significant progress has also been made towards scaling up access to antiretroviral treatment, the increase in new infections in certain regions, a decrease in funding, and the fact that under new WHO guidelines HIV patients should be starting their treatment regimens much earlier, means that universal access targets are way off track. As new infections continue to outstrip numbers on treatment by 2 to 1 in resource-limited settings, the scale of unmet need can only increase.

Funding research to develop a functional1 or sterilizing2 cure for HIV which could offer people living with the virus an alternative to the burden of a difficult life-long antiretroviral regimen is therefore in our collective economic interest. Furthermore, recent scientific advances and new approaches to tackling viral reservoirs, the main obstacle to finding a cure, strongly suggest that now is the right time to invest in and aggressively pursue an HIV cure.

The International AIDS Society has made HIV cure one of its policy priorities and Professor Franoise Barr-Sinoussi, co-discoverer of HIV, Nobel Laureate and IAS President-elect, is currently guiding the development of a global scientific strategy, Towards an HIV Cure. This strategy aims at building a global consensus on the state of the art research in the field of HIV reservoirs and defining scientific priorities that must be addressed to tackle HIV persistence in patients undergoing treatment, the key hurdle impeding any alternative to long-term therapy.

The IAS urges leaders at UNGASS to look towards the example of the eradication of the smallpox virus for motivation to ensure the inclusion of HIV cure research and its global Development.

In 1967, the World Health Organization (WHO) launched an ambitious scientific strategy to eradicate smallpox, which was pushed back to the horn of Africa and then to a single last natural case, which occurred in Somalia in 1977. Scientists working on HIV cure research are inspired by the eradication of smallpox, not because of similarities between the smallpox virus and HIV (HIV is a retrovirus, and biologically very different from smallpox), but because of how a clear and focused scientific strategy managed to eradicate a disease which threatened 60% of the world's population, killed every fourth victim, scarred or blinded most survivors, and eluded any form of treatment.

The 2011 High-Level Meeting on AIDS is a unique global opportunity for partners to meet and move the AIDS agenda forward, and the International AIDS Society strongly believes that the inclusion of HIV cure research in the global agenda is a time sensitive priority if we are ever to envisage the eradication of viral reservoirs and subsequently the long-term remission of infected individuals.


'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
41-227-100-822
International AIDS Society
Source:Eurekalert

Related medicine news :

1. UT Southwestern research teams anti-malarial work wins international Project of the Year award
2. Elsevier launches new journal: International Journal of Paleopathology
3. IUPUI behavioral neuroscientist receives international award for alcoholism research
4. 17th Annual International Sustainable Development Research Conference
5. International training to assist governments of 5 African nations in detecting poor-quality drugs
6. International organizations join forces to promote cardiovascular health
7. An international study in China finds strawberries may slow precancerous growth in the esophagus
8. EPIDEMICS(3) The Third International Conference on Infectious Disease Dynamics
9. 2nd International Conference on Immune Tolerance
10. International Diabetes Federation supports surgery to treat diabetes
11. International Open Access meeting comes to the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... Francisco, CA (PRWEB) , ... June 24, 2016 ... ... CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive ... self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces its ... The PluriQ™ G9™ Gene Editing System is a complete system for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially ... their medication by matching users with high quality water pipes within an ideal price ... commitment. , Inhale was founded by two brothers, Nick and Mike Hunter, who use ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: